Bioxytran Releases Positive Top-line Results from Phase 2 Tr

/PRNewswire/ -- BIOXYTRAN, INC. (OTCQB: BIXT), (the "Company"), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral...

Related Keywords

Boston , Massachusetts , United States , Michael Sheikh , Alben Sigamani , Hana Chen Walden , Nuclear Magnetic Resonance , Bioxytran Inc , Galectin Antagonist , Magnetic Resonance , N Terminal Domain , Bioxytran Medical Advisory Board , Medical Director , Bioxytran , Nc ,